November 21, 2006
Neurosurgeon, Mitchel Berger, MD, and head of American Brain Tumor Association, Naomi Berkowitz, cut the ribbon to officially open the Brain Tumor Patient Education Center. To complement the strong basic science and clinical research in brain tumors at UCSF, the Division of Neuro-Oncology has a ...November 21, 2006
"Treating illness means treating the whole patient," says Steven Pantilat, the physician who directs the UCSF Adult Palliative Care Service at the UCSF Medical Center at Parnassus. About half of the patients who consult with members of the service are cancer patients. Palliative care is ...November 21, 2006
One by one, the patients who created Art for Recovery's latest quilt scanned the panels looking for the quilt square they had made. It was both an emotional and stirring moment, as it was the first time many of them had seen the quilt in ...November 17, 2006
To his many friends and acquaintances, Dixon Heise epitomized the San Francisco gentleman: sharp in mind, witty yet gracious in manner. After his death last February at age 89, another aspect of his character was cast in sharp relief: his incredible generosity of spirit. A ...November 16, 2006
A vaccine for treating a recurrent cancer of the central nervous system that occurs primarily in the brain, known as glioma, has shown promising results in preliminary data from a clinical trial at UCSF Medical Center. Findings from the first group of six patients in ...November 15, 2006
A novel method for predicting the risk of prostate cancer recurrence following surgery that was developed by urologists at UCSF Medical Center has been validated in a recent study. The new method is named the UCSF Cancer of the Prostate Risk Assessment (CAPRA). It is ...November 14, 2006
A study of almost 600,000 men aged 70 and older reveals that 56 percent had a routine prostate-specific antigen (PSA) screening, a blood test for prostate cancer, even though no treatment guidelines recommend PSA screening for men of that age. Screening rates declined with age, ...November 9, 2006
The drug imatinib (Gleevec) is generally considered to be the most significant new entrant in the armamentarium of anticancer drugs in the past 20 years. Its approval in May 2001 was the cover story of Time magazine. In patients whose cancers had grown despite earlier ...October 31, 2006
Studies show that Asian populations have a lower incidence of chronic diseases, such as cancer, than their Western counterparts. One such study, by the National Cancer Institute, found that whites had a 65 percent higher rate of cancer mortality than Asian-Pacific Islanders from the years ...October 27, 2006
Cancer, diabetes, inflammation, malaria. The list of diseases ripe for new treatments is long. Yet the pace of drugs coming to market is actually flat. A key reason is the drug discovery process itself, says Jim Wells, director of the Small Molecule Discovery Center (SMDC) ...
Martin McMahon hopes to understand in greater detail the way that human cancers develop and respond to therapy.
Meet more of Our Heroes »#Cancer treatments vary due to location, in part due to "different financial incentives" @cooperberg_ucsf @HuffPostSF http://t.co/kkDt5r19fb
Copyright © 2012-2013 University of California Regents. All Rights Reserved.
UCSF Helen Diller Family Comprehensive Cancer Center
Site Map | Terms of Use & Privacy Policy | Contact Webmaster
Subscribe to RSS